Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06857448

Autologous Point-of-Care Adipose Therapy: Recent Injury

The goal of this study is to explore if an adipose-based therapeutic strategy can treat full-thickness soft-tissue trauma wounds in injured individuals, especially those with severe burns or soft-tissue loss. The main question it aims to answer are:

- Can immediate autologous adipose and autologous layered composite grafting be effective for acute functional soft-tissue reconstruction?

Researchers will compare the single-stage autologous layered composite grafting method to traditional methods to see if it improves healing outcomes, minimizes scarring, and reduces infection risk.

Participants will:

* Receive immediate fat grafting into the wound. * Undergo simultaneous split-thickness skin grafting for full soft-tissue reconstruction.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mercy Hospital, Pittsburgh, Pennsylvania, United States

Loading trial locations.

About this study

Soft-tissue injuries from blasts, burns, or multiple traumas can cause severe damage, leading to loss of function, lower quality of life, long recovery times, and inability to work. When these injuries involve deep burns or full-thickness tissue loss in areas that move a lot, they are especially difficult to treat due to the risk of scarring, stiffness, and tissue sticking together. There is a need for a reliable, single-stage treatment that can provide soft, flexible tissue reconstruction with minimal risk, cost, and, complexity. To address this issue, the investigators propose a fat-based approach to reconstruction. Fat tissue is easily available from the patient's own body and carries many benefits in reconstructive surgery. Our team has shown that using a layer of fat immediately in treatment creates a soft, vascular layer that reduces scarring, improves tissue volume, and supports a one-stage, multi-layer reconstruction without the need for complex surgery or causing harm to the donor area. The purpose of this study is to compare this reconstructive approach under the following conditions:

  • Demonstrate efficacy of immediate autologous adipose and autologous layered Composite Grafting in acute functional soft-tissue reconstruction.

Evaluators including dedicated observers will be blinded to treatment group/strategy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The proposed study will include adult patients 18 years of age or older,
  • male or female,
  • civilian, military, active duty or retired veterans
  • presenting for unilateral or bilateral fasciotomy of the extremity at any level necessary
  • secondary to non-infectious etiology,
  • unilateral or bilateral traumatic full-thickness skin loss of the face, head, neck or extremities necessitating reconstruction, and/or
  • full or partial thickness burn injury of the face, neck, or extremity requiring excision and/or reconstruction.
  • Additional inclusion criteria includes willingness to be randomized to receive a fat graft.

Exclusion criteria

  • Age < 18 years of age,
  • active infection,
  • medical co-morbidities or anatomic configuration deemed by the physician to be a concern for safety,
  • unwilling or unable to comply with study procedures,
  • radiation to the site of interest,
  • prisoners and/or vulnerable populations.
  • In addition, candidates that are pregnant or plan to become pregnant in the next year, will be excluded.

Treatment and study plan

Split Thickness Skin Graft (STSG)

Procedure

Partial thickness skin in STSGs are performed by harvesting via dermatome the donor site. Donor sites are typically taken from a flat surface on the thigh, lower back, or gluteal region to allow for a graft of even thickness and the selection of donor site is to be based on clinical standard practice. These grafts are placed on the prepared recipient site.

Base of wound fat graft with STSG Reconstruction (Autologous Layered Composite Grafting).

Procedure

Autologous Layered Composite Grafting consists of the layered strategy of simultaneous fat and skin grafting. Fat is harvested by minimally invasive liposuction and applied directly to the wound base without any chemical or biologic processing. Skin is harvested as a split thickness skin graft by dermatome and applied over the layer of adipose tissue.

Primary outcomes

  1. Total score on the Patient and Observer Scar Assessment Scale (POSAS): Pigmentation, Pliability, Vascularity, Thickness, Relief, and Surface Area, collected at the 9 month follow up visit.

    Time frame: From surgery to 9-month clinical endpoint.

    POSAS measures subjective assessment on a 1-10 scale from normal skin to worst scar imaginable across 6 metrics (surface area, vascularity, pigmentation, thickness, pliability and relief). The lowest sum score, reflecting normal skin, is 6 and the highest score, reflecting the worst imaginable scar, is 60.

Secondary outcomes

  1. Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability).

    Time frame: From surgery to 9-month clinical endpoint.

    Incidence of adverse events will be reported for all study participants.

  2. Number of Operative Encounters

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will additionally assess early outcome metrics including number of operative encounters.

  3. Percent Graft Take

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will additionally assess early outcome metrics including percent graft take (% of surface area).

  4. Time to Final Healing/Graft Take

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will additionally assess early outcome metrics including, time to final healing/graft take in days.

  5. Photographic Appearance of Wound

    Time frame: From surgery to 9-month clinical endpoint.

    Photographic evaluation for wound appearance. This is gross appearance.

  6. Area of Wound

    Time frame: From surgery to 9-month clinical endpoint.

    Photographic evaluation for size of wound area. This is measured in cm2

  7. Tissue Thickness

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will measure tissue thickness as determined by ultrasound.

  8. Pliability (Tensiometry/Cutometry)

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will utilize a noninvasive cutometer/tensiometer to determine tissue pliability.

  9. Tissue Mobility (Resistance to Adhesion)

    Time frame: From surgery to 9-month clinical endpoint.

    The investigators will measure tissue mobility under non-invasive tissue stretch. Measurement is achieved by the mm of stretch achievable from a given point under a standardized stress.

Study contacts

Contact information is provided by the study sponsor or research team.

Eleanor Shirley

CONTACT

[email protected]

412-641-8676

Patsy Simon

CONTACT

[email protected]

412-641-8676

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • Armed Forces Institute of Regenerative Medicine

Registry information

Official study title

Autologous Point-of-Care Adipose Therapy for Reconstruction and Regeneration of Traumatized Skin: Recent Injury

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Mar 4, 2025
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.